Cargando…
Time for a regulatory framework for pediatric medications in Canada
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CMA Impact Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438731/ https://www.ncbi.nlm.nih.gov/pubmed/35577378 http://dx.doi.org/10.1503/cmaj.220044 |
| _version_ | 1784781894968147968 |
|---|---|
| author | Gilpin, Andrea Bérubé, Sophie Moore-Hepburn, Charlotte Lacaze-Masmonteil, Thierry Samiee-Zafarghandy, Samira Rieder, Michael Gruenwoldt, Emily MacLeod, Stuart Litalien, Catherine |
| author_facet | Gilpin, Andrea Bérubé, Sophie Moore-Hepburn, Charlotte Lacaze-Masmonteil, Thierry Samiee-Zafarghandy, Samira Rieder, Michael Gruenwoldt, Emily MacLeod, Stuart Litalien, Catherine |
| author_sort | Gilpin, Andrea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9438731 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | CMA Impact Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94387312022-09-03 Time for a regulatory framework for pediatric medications in Canada Gilpin, Andrea Bérubé, Sophie Moore-Hepburn, Charlotte Lacaze-Masmonteil, Thierry Samiee-Zafarghandy, Samira Rieder, Michael Gruenwoldt, Emily MacLeod, Stuart Litalien, Catherine CMAJ Commentary CMA Impact Inc. 2022-05-16 2022-05-16 /pmc/articles/PMC9438731/ /pubmed/35577378 http://dx.doi.org/10.1503/cmaj.220044 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Commentary Gilpin, Andrea Bérubé, Sophie Moore-Hepburn, Charlotte Lacaze-Masmonteil, Thierry Samiee-Zafarghandy, Samira Rieder, Michael Gruenwoldt, Emily MacLeod, Stuart Litalien, Catherine Time for a regulatory framework for pediatric medications in Canada |
| title | Time for a regulatory framework for pediatric medications in Canada |
| title_full | Time for a regulatory framework for pediatric medications in Canada |
| title_fullStr | Time for a regulatory framework for pediatric medications in Canada |
| title_full_unstemmed | Time for a regulatory framework for pediatric medications in Canada |
| title_short | Time for a regulatory framework for pediatric medications in Canada |
| title_sort | time for a regulatory framework for pediatric medications in canada |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438731/ https://www.ncbi.nlm.nih.gov/pubmed/35577378 http://dx.doi.org/10.1503/cmaj.220044 |
| work_keys_str_mv | AT gilpinandrea timeforaregulatoryframeworkforpediatricmedicationsincanada AT berubesophie timeforaregulatoryframeworkforpediatricmedicationsincanada AT moorehepburncharlotte timeforaregulatoryframeworkforpediatricmedicationsincanada AT lacazemasmonteilthierry timeforaregulatoryframeworkforpediatricmedicationsincanada AT samieezafarghandysamira timeforaregulatoryframeworkforpediatricmedicationsincanada AT riedermichael timeforaregulatoryframeworkforpediatricmedicationsincanada AT gruenwoldtemily timeforaregulatoryframeworkforpediatricmedicationsincanada AT macleodstuart timeforaregulatoryframeworkforpediatricmedicationsincanada AT litaliencatherine timeforaregulatoryframeworkforpediatricmedicationsincanada |